October 1, 2021 -- Eagle Genomics and the Earlham Institute have entered into a partnership that is focused on providing tools required to analyze, explore, and leverage complex microbiome data.
The partnership will include collaborative R&D, consultancy work, licensing, as well as deploying Eagle's hosting and networking capabilities. It will also provide strategic insight as part of a steering group on new pipelines, the organizations said in a joint statement.
This could include research into the following areas: